Heidi Kay
CEO/Founder
Jericho Sciences
Durham (RTP), North Carolina, United States
Developing novel antivirals to address public health unmet needs to clear chronic infections and prepare for potential emerging viruses.
My organisation
About me
As a PhD chemist, I first worked in academia teaching and researching in chemistry, cancer and other public health areas, including water/wastewater, air pollution and global health. In 2009, I founded an R&D company to transition my anticancer research accomplishments into antiviral applications. Jericho Sciences continues to be funded through highly competitive nondilutive NIH grant awards to develop new antiviral therapies for unmet public health needs. I am passionate about finding beneficial solutions and improving the quality of life.